← All trials
NCT05703971
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2023
- Primary completion
- Feb 28, 2026
- Completion date
- Aug 31, 2027
- First posted
- Jan 30, 2023
- Last posted
- Mar 24, 2023
- Enrollment
- 62
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Genprex, Inc.Lead sponsor
- Genprex, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.